Home LiteratureArticle Details
PMID: 12324251 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S. Review

Two-component and phosphorelay signal-transduction systems as therapeutic targets.

Current opinion in pharmacology ·Vol. 2 ·No. 5 ·2002-10-00 ·Pages 507-12

Stephenson K, Hoch JA

Abstract

Two-component and phosphorelay signal-transduction systems of pathogenic bacteria control the expression of genes encoding virulence factors and essential functions. Recent systematic gene inactivation studies have confirmed the integral role of two-component systems in the pathogenesis of diseases caused by several microorganisms and highlighted the validity of using these systems as targets for therapeutic intervention. Structural studies of signal-transduction proteins have recently revealed common features that may allow rational drug design for therapeutic intervention. In particular, the conserved domains of response regulators may represent the best targets for inhibition.

MeSH Terms
Amino Acid Sequence Anti-Bacterial Agents/pharmacology Bacteria/drug effects,genetics,metabolism Bacterial Infections/microbiology Drug Design Molecular Conformation Signal Transduction/drug effects
Chemicals
Anti-Bacterial Agents
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Stephenson Keith
Department of Molecular and Experimental Medicine, MEM-116, The Scripps Research Institute, La Jolla, California 92037, USA.
Hoch James A
Article Info
Journal
Current opinion in pharmacology
Abbr.
Curr Opin Pharmacol
ISSN
1471-4892
Published
2002-10-00
Pages
507-12
Language
English
Region
England
NLM ID
100966133
Subset
IM
Grants
NIGMS NIH HHS · GM19416 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com